QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

22,844 signal articles · 274 in last 24h · 109,535 total before filter · latest 32m ago
274last 24h
2510last 7d
466● bullish (7d)
238● bearish (7d)
202publishers
AllMacro238Earnings1548M&A105Regulatory17Product16Analyst24
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Celestica shares slide after launching $3 billion equity offering
InvestorsHub4d agoneutral
Celestica shares slide after launching $3 billion equity offering

Celestica (NYSE:CLS) shares dropped around 15% on Thursday after the electronics manufacturing company announced a $3 billion public share offering priced at a discount to its previous closing price. The capital raise is intended to strengthen the company’s balance sheet and support future investment, although the discounted pricing weighed heavily on investor sentiment.

Moderna Stock Rises After mRNA Flu Shot Approval
The Wall Street Journal4d agoneutral
Moderna Stock Rises After mRNA Flu Shot Approval

Shares in Moderna ticked higher after the biotech secured Food and Drug Administration approval for its mRNA flu vaccine for use in adults aged 50 and older. The FDA's decision capped an arduous seven-month process that included a rare refusal by the regulator to consider the shot.

Broad-Based Growth Lifted West Pharmaceuticals (WST) in Q2
Insider Monkey4d agoneutral
Broad-Based Growth Lifted West Pharmaceuticals (WST) in Q2

Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 Index achieving its best first half since 1991 and the Russell 2000 Growth Index up 25.7% in Q2, fueled by AI […]